DMI/FDA/1.1.2/Evolve

Surpass Evolve Flow Diverter, Stryker – Sim&Size v1.1.2

 

Indication for use (P170024/S003)

The Surpass Evolve Flow Diverter System is indicated for use in the endovascular treatment of patients (18 years of age and older) with unruptured large or giant saccular wide-neck (neck width  4 mm or dome-to-neck ratio < 2) or fusiform intracranial aneurysms in the internal carotid artery from the petrous segment to the terminus arising from a parent vessel with a diameter  2.5 mm and ≤  5.0 mm.